Australia markets closed
ASX 200
7,814.40 -66.90 (-0.85%) AUD/USD
0.6665 -0.0015 (-0.23%) OIL
79.75 +0.52 (+0.66%) GOLD
2,397.60 +12.10 (+0.51%) Bitcoin AUD
99,651.12 +538.73 (+0.54%) CMC Crypto 200
1,355.21 -18.63 (-1.36%)
Acumen Pharmaceuticals, Inc. (ABOS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 224.10M |
| Enterprise value | -442.43k |
| Trailing P/E | 4.40 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.86 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.19 |
| 52-week change 3 | -37.42% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 11.3100 |
| 52-week low 3 | 1.8100 |
| 50-day moving average 3 | 3.7246 |
| 200-day moving average 3 | 3.9297 |
Share statistics
| Avg vol (3-month) 3 | 309.2k |
| Avg vol (10-day) 3 | 165.97k |
| Shares outstanding 5 | 60.08M |
| Implied shares outstanding 6 | 60.08M |
| Float 8 | 32.28M |
| % held by insiders 1 | 11.24% |
| % held by institutions 1 | 73.65% |
| Shares short (30 Apr 2024) 4 | 926.85k |
| Short ratio (30 Apr 2024) 4 | 4.05 |
| Short % of float (30 Apr 2024) 4 | 2.07% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.54% |
| Shares short (prior month 28 Mar 2024) 4 | 1.24M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -15.08% |
| Return on equity (ttm) | -22.98% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -61.08M |
| Net income avi to common (ttm) | -52.37M |
| Diluted EPS (ttm) | -1.0800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 243.52M |
| Total cash per share (mrq) | 4.05 |
| Total debt (mrq) | 31.05M |
| Total debt/equity (mrq) | 11.63% |
| Current ratio (mrq) | 19.01 |
| Book value per share (mrq) | 4.61 |
Cash flow statement
| Operating cash flow (ttm) | -43.06M |
| Levered free cash flow (ttm) | -28.24M |
© 2024 Yahoo. All rights reserved.